Your browser doesn't support javascript.
loading
Patient preferences for maintenance PARP inhibitor therapy in ovarian cancer treatment.
Havrilesky, Laura J; Lim, Stephanie; Ehrisman, Jessie A; Lorenzo, Amelia; Alvarez Secord, Angeles; Yang, Jui-Chen; Johnson, F Reed; Gonzalez, Juan Marcos; Reed, Shelby D.
Afiliação
  • Havrilesky LJ; Division of Gynecologic Oncology, Duke University Medical Center, Durham, NC, United States of America; Department of Obstetrics and Gynecology, Duke University Medical Center, Durham, NC, United States of America; Duke Cancer Institute, Duke University Medical Center, Durham, NC, United States of A
  • Lim S; Department of Obstetrics and Gynecology, Duke University Medical Center, Durham, NC, United States of America.
  • Ehrisman JA; Division of Gynecologic Oncology, Duke University Medical Center, Durham, NC, United States of America.
  • Lorenzo A; Division of Gynecologic Oncology, Duke University Medical Center, Durham, NC, United States of America.
  • Alvarez Secord A; Division of Gynecologic Oncology, Duke University Medical Center, Durham, NC, United States of America; Department of Obstetrics and Gynecology, Duke University Medical Center, Durham, NC, United States of America; Duke Cancer Institute, Duke University Medical Center, Durham, NC, United States of A
  • Yang JC; Duke Clinical Research Institute, Duke University School of Medicine, Durham, NC, United States of America.
  • Johnson FR; Duke Clinical Research Institute, Duke University School of Medicine, Durham, NC, United States of America; Department of Population Health Sciences, Duke University School of Medicine, Durham, NC, United States of America.
  • Gonzalez JM; Duke Clinical Research Institute, Duke University School of Medicine, Durham, NC, United States of America; Department of Population Health Sciences, Duke University School of Medicine, Durham, NC, United States of America.
  • Reed SD; Duke Cancer Institute, Duke University Medical Center, Durham, NC, United States of America; Duke Clinical Research Institute, Duke University School of Medicine, Durham, NC, United States of America; Department of Population Health Sciences, Duke University School of Medicine, Durham, NC, United St
Gynecol Oncol ; 156(3): 561-567, 2020 03.
Article em En | MEDLINE | ID: mdl-31982178
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Ovarianas / Preferência do Paciente / Inibidores de Poli(ADP-Ribose) Polimerases Tipo de estudo: Prognostic_studies / Qualitative_research Limite: Female / Humans / Middle aged País/Região como assunto: America do norte Idioma: En Revista: Gynecol Oncol Ano de publicação: 2020 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Ovarianas / Preferência do Paciente / Inibidores de Poli(ADP-Ribose) Polimerases Tipo de estudo: Prognostic_studies / Qualitative_research Limite: Female / Humans / Middle aged País/Região como assunto: America do norte Idioma: En Revista: Gynecol Oncol Ano de publicação: 2020 Tipo de documento: Article